{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:06:45Z","timestamp":1789200405927,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004784","name":"Novartis Foundation for Medical-Biological Research","doi-asserted-by":"publisher","award":["23B083"],"award-info":[{"award-number":["23B083"]}],"id":[{"id":"10.13039\/501100004784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["10006641"],"award-info":[{"award-number":["10006641"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["310030_182317"],"award-info":[{"award-number":["310030_182317"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["310030_184816"],"award-info":[{"award-number":["310030_184816"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ymgmr.2026.101345","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T16:30:20Z","timestamp":1785774620000},"page":"101345","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Empagliflozin in GSD-Ib: Long-term safety and sustained recovery of neutrophil function including NET formation"],"prefix":"10.1016","volume":"48","author":[{"given":"D\u00e9borah","family":"Mathis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Felser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Hochuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Ballhausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Boros-Majewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Bourquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Uwe","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Gautschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darko","family":"Stojkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgmr.2026.101345_bb0005","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1086\/302068","article-title":"A gene on chromosome 11q23 coding for a putative glucose- 6-phosphate translocase is mutated in glycogen-storage disease types Ib and Ic","volume":"63","author":"Veiga-da-Cunha","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgmr.2026.101345_bb0010","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1042\/bj3620513","article-title":"The glucose-6-phosphatase system","volume":"362","author":"van Schaftingen","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgmr.2026.101345_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1145111","article-title":"Current understanding on pathogenesis and effective treatment of glycogen storage disease type Ib with empagliflozin: new insights coming from diabetes for its potential implications in other metabolic disorders","volume":"14","author":"Maiorana","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.ymgmr.2026.101345_bb0020","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.3748\/wjg.v29.i25.3932","article-title":"Glycogen storage diseases: an update","volume":"29","author":"Gumus","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ymgmr.2026.101345_bb0025","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1038\/gim.2014.128","article-title":"Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics","volume":"16","author":"Kishnani","year":"2014","journal-title":"Genet. Med."},{"issue":"10","key":"10.1016\/j.ymgmr.2026.101345_bb0030","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.3390\/diagnostics13101803","article-title":"Treatment of the neutropenia associated with GSD1b and G6PC3 deficiency with SGLT2 inhibitors","volume":"13","author":"Veiga-da-Cunha","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.ymgmr.2026.101345_bb0035","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1073\/pnas.1816143116","article-title":"Failure to eliminate a phosphorylated glucose analog leads to neutropenia in patients with G6PT and G6PC3 deficiency","volume":"116","author":"Veiga-da-Cunha","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgmr.2026.101345_bb0040","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/jimd.12187","article-title":"Inborn errors of metabolite repair","volume":"43","author":"Veiga-da-Cunha","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2026.101345_bb0045","first-page":"55","article-title":"1,5-Anhydro-D-glucitol--a novel type of sugar in the human organism","volume":"201","author":"Pitkanen","year":"1990","journal-title":"Scand. J. Clin. Lab. Investig. Suppl."},{"key":"10.1016\/j.ymgmr.2026.101345_bb0050","first-page":"E268","article-title":"Origin and disposal of 1,5-anhydroglucitol, a major polyol in the human body","volume":"263","author":"Yamanouchi","year":"1992","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.ymgmr.2026.101345_bb0055","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1182\/blood.2019004465","article-title":"Treating neutropenia and neutrophil dysfunction in glycogen storage disease type Ib with an SGLT2 inhibitor","volume":"136","author":"Wortmann","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.ymgmr.2026.101345_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2024.108144","article-title":"Treatment recommendations for glycogen storage disease type IB- associated neutropenia and neutrophil dysfunction with empagliflozin: consensus from an international workshop","volume":"141","author":"Grunert","year":"2024","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2026.101345_bb0065","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1067\/mpd.2000.105232","article-title":"Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib: results of the European study on glycogen storage disease type I","volume":"137","author":"Visser","year":"2000","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgmr.2026.101345_bb0070","first-page":"529","article-title":"Recombinant human G-CSF (Lenograstim) for infectious complications in glycogen storage disease type Ib. Report of 7 cases","volume":"35","author":"Donadieu","year":"1994","journal-title":"Nouv. Rev. Fr. Hematol."},{"key":"10.1016\/j.ymgmr.2026.101345_bb0075","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/MOH.0000000000000474","article-title":"Neutropenia in glycogen storage disease Ib: outcomes for patients treated with granulocyte colony-stimulating factor","volume":"26","author":"Dale","year":"2019","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.ymgmr.2026.101345_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2024.108486","article-title":"Empagliflozin for treating neutropenia and neutrophil dysfunction in 21 infants with glycogen storage disease 1b","volume":"142","author":"Grunert","year":"2024","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2026.101345_bb0085","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13023-022-02345-2","article-title":"Understanding the role of SGLT2 inhibitors in glycogen storage disease type Ib: the experience of one UK centre","volume":"17","author":"Halligan","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2026.101345_bb0090","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1182\/bloodadvances.2023012403","article-title":"Neutrophil functions in patients with neutropenia due to glycogen storage disease type 1b treated with empagliflozin","volume":"8","author":"Kaczor","year":"2024","journal-title":"Blood Adv."},{"key":"10.1016\/j.ymgmr.2026.101345_bb0095","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/eji.201747053","article-title":"Untangling \u201cNETosis\u201d from NETs","volume":"49","author":"Yousefi","year":"2019","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ymgmr.2026.101345_bb0100","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1083\/jcb.201611168","article-title":"ROS and glutathionylation balance cytoskeletal dynamics in neutrophil extracellular trap formation","volume":"216","author":"Stojkov","year":"2017","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ymgmr.2026.101345_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1272699","article-title":"Syntaxin-4 and SNAP23 are involved in neutrophil degranulation, but not in the release of mitochondrial DNA during NET formation","volume":"14","author":"Gigon","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymgmr.2026.101345_bb0110","doi-asserted-by":"crossref","first-page":"eabm0517","DOI":"10.1126\/scisignal.abm0517","article-title":"NET formation is independent of gasdermin D and pyroptotic cell death","volume":"16","author":"Stojkov","year":"2023","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ymgmr.2026.101345_bb0115","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1038\/cdd.2009.96","article-title":"Viable neutrophils release mitochondrial DNA to form neutrophil extracellular traps","volume":"16","author":"Yousefi","year":"2009","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ymgmr.2026.101345_bb0120","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/j.gim.2022.04.001","article-title":"Efficacy and safety of empagliflozin in glycogen storage disease type Ib: data from an international questionnaire","volume":"24","author":"Grunert","year":"2022","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgmr.2026.101345_bb0125","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.cca.2018.07.018","article-title":"Reference intervals for serum 1,5-anhydroglucitol in children, adolescents, adults, and pregnant women","volume":"486","author":"Welter","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgmr.2026.101345_bb0130","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1038\/s41467-018-05387-y","article-title":"Neutrophil extracellular trap formation requires OPA1-dependent glycolytic ATP production","volume":"9","author":"Amini","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymgmr.2026.101345_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001794","article-title":"Nascent RHOH acts as a molecular brake on actomyosin-mediated effector functions of inflammatory neutrophils","volume":"20","author":"Peng","year":"2022","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ymgmr.2026.101345_bb0140","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00018-023-04884-8","article-title":"SGLT5 is the renal transporter for 1,5-anhydroglucitol, a major player in two rare forms of neutropenia","volume":"80","author":"Diederich","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ymgmr.2026.101345_bb0145","doi-asserted-by":"crossref","DOI":"10.1002\/jimd.70198","article-title":"Shifting towards empagliflozin first-line therapy in glycogen storage disease type Ib: a nationwide real-world study","volume":"49","author":"Ucar","year":"2026","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2026.101345_bb0150","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.ymgmr.2026.101345_bb0155","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.jaci.2020.02.038","article-title":"The role of neutrophils in host defense and disease","volume":"145","author":"Lehman","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ymgmr.2026.101345_bb0160","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1182\/blood-2002-10-3128","article-title":"Apoptotic neutrophils in the circulation of patients with glycogen storage disease type 1b (GSD1b)","volume":"101","author":"Kuijpers","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ymgmr.2026.101345_bb0165","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s13023-024-03137-6","article-title":"Clinical spectrum, over 12-year follow-up and experience of SGLT2 inhibitors treatment on patients with glycogen storage disease type Ib: a single-center retrospective study","volume":"19","author":"Shao","year":"2024","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgmr.2026.101345_bb0170","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s40291-025-00795-5","article-title":"Clinical and genetic profile of 35 patients with glycogen storage disease type 1b: a comparative analysis before and during SGLT2 inhibitor therapy","volume":"29","author":"Milosevic","year":"2025","journal-title":"Mol. Diagn. Ther."}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426926000571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426926000571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T07:48:35Z","timestamp":1789199315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426926000571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":34,"alternative-id":["S2214426926000571"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2026.101345","relation":{},"ISSN":["2214-4269"],"issn-type":[{"value":"2214-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Empagliflozin in GSD-Ib: Long-term safety and sustained recovery of neutrophil function including NET formation","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2026.101345","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101345"}}